← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Naprogenix, Inc
Lexington, KY
$19,726,658
Total funding
19
Grants
Funding over time
peak $3M · FY2006–24$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$19,726,658 · 19
By mechanism
R44$8,013,730 · 4
U44$4,981,667 · 1
R42$3,687,564 · 4
N44$1,434,887 · 2
R41$858,110 · 5
R43$750,700 · 3
Investigators at Naprogenix, Inc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Development of JR-220 (4-Chlorobenzylidenamino-guanidine hydrochloride) as a medication for alcohol dependence$1,404,983
U44 · FY2022 · AA
Development of JR-220 (4-Chlorobenzylidenamino-guanidine hydrochloride) as a medication for alcohol dependence$1,016,716
U44 · FY2021 · AA
Novel Pharmacotherapies for Alcoholism$999,423
N44 · FY2013 · HD
Development of JR-220 (4-Chlorobenzylidenamino-guanidine hydrochloride) as a medication for alcohol dependence$993,323
U44 · FY2023 · AA
Novel modulators of the dopamine transporter for alcohol and nicotine use disorders$975,562
R44 · FY2021 · AA
Novel modulators of the dopamine transporter for alcohol and nicotine use disorders$966,417
R44 · FY2022 · AA
Novel modulators of the dopamine transporter for alcohol and nicotine use disorders$890,494
R44 · FY2020 · AA
Development of JR-220 (4-Chlorobenzylidenamino-guanidine hydrochloride) as a medication for alcohol dependence$794,605
U44 · FY2018 · AA
Development of JR-220 (4-Chlorobenzylidenamino-guanidine hydrochloride) as a medication for alcohol dependence$672,530
U44 · FY2017 · AA
Mimicking synuclein toxicity in plant cells to identify novel neuroprotective leads$624,004
R44 · FY2020 · NS
Mimicking synuclein toxicity in plant cells to identify novel neuroprotective leads$617,521
R44 · FY2021 · NS
Mimicking synuclein toxicity in plant cells to identify novel neuroprotective leads$617,512
R44 · FY2022 · NS
Harvesting specific plant metabolites from hairy root cultures using magnetized nanoparticles$530,326
R44 · FY2017 · AT
Selection-driven plant metabolites for treatment of CNS diseases$516,666
R44 · FY2013 · AA
Harvesting specific plant metabolites from hairy root cultures using magnetized nanoparticles$498,691
R44 · FY2018 · AT
Mutant transgenic plant cells as a novel source of drugs$489,617
R44 · FY2017 · AA
Selection-driven plant metabolites for treatment of CNS diseases$487,620
R44 · FY2014 · AA
Mutant transgenic plant cells as a novel source of drugs$455,773
R44 · FY2016 · AA
Hypericum extracts as potential anti-relapse medications in alcoholism$374,855
R42 · FY2009 · AA
Hypericum extracts as potential anti-relapse medications in alcoholism$370,355
R42 · FY2010 · AA